Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters








Publication year range
1.
Clin Exp Dermatol ; 34(8): e599-601, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19486057

ABSTRACT

Pilonidal sinuses usually occur in the sacrococcygeal area in young men, and occasionally can be found in other ectopic sites. We present a retrospective case review on unusual locations of pilonidal sinuses in the past 4 years. The lesion sites were as follows: one on the penis, two on the scalp, two on the abdomen, one on the neck, two in the groin and two in the axilla. Abdominal and penile lesions are uncommon, but the other locations reported are unusually rare. To our knowledge, the groin has not been reported previously as a site of a pilonidal sinus, although the histological appearance of hidradenitis suppurativa may well resemble it. When trying to clarify the pathogenesis of these occurrences, we found that recurrent hair removal was a common characteristic of the patients we contacted, and this may have been the initiating trauma.


Subject(s)
Hair Removal/adverse effects , Hidradenitis Suppurativa/pathology , Pilonidal Sinus/pathology , Adult , Female , Groin/pathology , Humans , Male , Neck/pathology , Penis/pathology , Pilonidal Sinus/etiology , Recurrence , Retrospective Studies , Scalp/pathology , Young Adult
2.
Analyst ; 133(3): 372-8, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18299752

ABSTRACT

Infrared spectroscopy is widely perceived as a future technology for cancer detection and grading. Malignant melanoma, an aggressive skin cancer, is accessible to non-invasive IR radiation based surface probes for its identification and grading. The present work examines the differences in the IR spectra of melanoma tissues and the surrounding epidermis in skin biopsies with the objective of identifying diagnostic parameters and suitable computational/statistical methods of analysis. Melanoma could be differentiated from the epidermis in biopsies of 55 patients, using parameters derived from absorbance bands originating from molecular vibrations of nucleic acids and/or their bases. Additionally, absorbances from tyrosine and phosphate that are abnormally elevated in malignant melanoma could be used as markers. Two-dimensional plots of these parameters in tandem with advanced statistical methods successfully demonstrate the potential of IR spectroscopy to distinguish between epidermal and melanoma regions with a high classification success. The work underlines the importance of developing data analysis methods in FTIR based diagnosis using melanoma as a model system.


Subject(s)
Biomarkers, Tumor/analysis , DNA, Neoplasm/analysis , Epidermis/chemistry , Melanoma/diagnosis , Skin Neoplasms/diagnosis , Cytosine/analysis , Discriminant Analysis , Guanine/analysis , Humans , Microspectrophotometry/methods , Spectroscopy, Fourier Transform Infrared/methods , Tyrosine/analysis
4.
J Dermatolog Treat ; 16(1): 19-21, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15897162

ABSTRACT

BACKGROUND: Paclitaxel and trastuzumab are new treatments for patients with metastatic breast cancer. CASE REPORT: We describe here a 40-year-old female patient with metastatic breast cancer who developed a photosensitive rash 1 month after initiation of paclitaxel and trastuzumab therapy. The eruption appeared on the dorsal aspect of her hands, forearms, legs and face and consisted of erythema, edema and vesicles, and was associated with distal onycholysis. Aberrations in various parameters of the metabolism of porphyrins were observed in urine and erythrocytes. Sun avoidance and withdrawal of paclitaxel was followed by resolution of the rash and a return to the normal pattern of porphyrins biosynthesis. CONCLUSION: The combination of paclitaxel and trastuzumab treatment and sun exposure may induce a photosensitive reaction, associated with changes in various parameters of porphyrins biosynthesis.


Subject(s)
Antibodies, Monoclonal/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Breast Neoplasms/drug therapy , Paclitaxel/adverse effects , Photosensitivity Disorders/chemically induced , Porphyrins/biosynthesis , Adult , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Female , Humans , Paclitaxel/therapeutic use , Trastuzumab
5.
J Eur Acad Dermatol Venereol ; 17(5): 596-7, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12941107

ABSTRACT

We describe a patient with an unusual presentation of multiple arteriovenous haemangioma (AVH) grouped in one area of the scalp. The diagnosis was confirmed by histological, X-ray and ultrasound studies. These lesion represent a rare, benign, acquired vascular hamartomatous formation that arises from the suprapapillary vascular plexus.


Subject(s)
Hemangioma/pathology , Skin Neoplasms/pathology , Adult , Biopsy, Needle , Female , Follow-Up Studies , Hemangioma/diagnosis , Hemangioma/surgery , Humans , Immunohistochemistry , Neoplasm Staging , Risk Assessment , Scalp , Skin Neoplasms/diagnosis , Skin Neoplasms/surgery , Treatment Outcome
6.
J Paediatr Child Health ; 39(3): 229-31, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12654150

ABSTRACT

A 7-month-old infant developed a discrete pustular rash confined to both soles during the acute phase of Kawasaki disease. Histological examination of a pustular lesion from the sole of a foot showed subcorneal neutrophilic microabscesses, psoriasiform acanthosis with a thin granular layer and mononuclear perivascular infiltrates in the upper dermis, consistent with psoriasis. Following the standard treatment with intravenous gamma globulin, the initial symptoms and signs of Kawasaki disease resolved completely. Eight weeks later, psoriasiform plaques appeared on both cheeks and on the extensor surfaces of the forearms and legs. Skin biopsy from one of these lesions revealed psoriasiform epidermal hyperplasia, focal parakeratosis and dilated papillary capillaries. The patient was treated with mild-potency topical steroids that resulted in rapid and complete resolution of the skin lesions. Concurrent association of psoriatic skin lesions and Kawasaki disease might not be incidental and could stem from a common pathogenetic mechanism induced by superantigens.


Subject(s)
Mucocutaneous Lymph Node Syndrome/complications , Mucocutaneous Lymph Node Syndrome/diagnosis , Psoriasis/complications , Psoriasis/diagnosis , Acute Disease , Administration, Topical , Biopsy, Needle , Follow-Up Studies , Foot Dermatoses/complications , Foot Dermatoses/diagnosis , Foot Dermatoses/drug therapy , Humans , Immunohistochemistry , Infant , Male , Psoriasis/drug therapy , Risk Assessment , Severity of Illness Index , Steroids/administration & dosage , Treatment Outcome
8.
Pediatr Dermatol ; 19(5): 382-7, 2002.
Article in English | MEDLINE | ID: mdl-12383092

ABSTRACT

We report unusual congenital ichthyosiform dermatosis in 5 of 12 children in two related families of unaffected, consanguineous Bedouin parents. It appeared shortly after birth as a fine peeling of nonerythematous skin on palms and soles. Gradually it evolved into prominent, well-demarcated areas of peeling skin in moist and traumatized regions. The cutaneous manifestations share features of ichthyosis bullosa of Siemens (IBS) and peeling skin syndrome (PSS). Histologic examination revealed orthokeratosis, a thickened granular cell layer, and spongiosis without epidermolytic hyperkeratosis. On electron microscopy there was prominent intercellular edema and numerous aggregates of keratin filaments in basal keratinocytes. This combination of clinical, histologic, and ultrastructural features has not been previously reported in the heterogeneous group of congenital ichthyoses. We suggest that it represents a new variant of exfoliative ichthyosis.


Subject(s)
Genes, Recessive , Ichthyosis/genetics , Adolescent , Dermatologic Agents/therapeutic use , Female , Humans , Ichthyosis/diagnosis , Ichthyosis/drug therapy , Ichthyosis/pathology , Infant , Infant, Newborn , Male , Pedigree
10.
Ann Plast Surg ; 47(3): 299-302, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11562035

ABSTRACT

In common practice, patients with incompletely excised basal cell carcinomas (BCCs) are referred to elective reexcision. In previous reports, it was observed that tumor cells are found in only 50% of the reexcised specimens. The authors performed a retrospective analysis of a large series of patients to evaluate clinical and pathological findings in patients who underwent reexcision of incompletely excised BCCs. A total of 1,478 BCCs arising in 1,278 patients were excised by plastic surgeons in a plastic and reconstructive surgery department during a 4-year period. In 159 patients (10.8%), the excision was incomplete according to the pathological report. These tumors were defined as an incompletely excised BCCs. One hundred of the 159 patients with incompletely excised BCCs (62.9%) were reoperated. Residual tumor cells were found in 28 of 100 patients (28%) within the pathological specimen of the reexcised tissue (defined as positive reexcision, or +veRE). There was no correlation between +veRE and the age or sex of the patient. Location of the BCCs in the cheeks, eyelids, or ears was associated with a low percent of +veRE (10.0%, 13.3%, and 22.2% respectively). Pathological factors associated with a low percent of +veRE were dermal inflammatory infiltrate in the pathological specimen (p = 0.003) and sun damage pathological changes (p = 0.03), but there was no correlation with the pathological subtype distribution of the tumors. The authors conclude that lack of tumor cells at reexcision of incompletely excised BCCs is associated with location of the tumors in the cheeks, eyelids, and ears, and with pathological findings of dermal inflammatory infiltrates or sun damage changes. The roles of inflammatory and solar changes in the destruction of residual carcinoma cells should be investigated further.


Subject(s)
Carcinoma, Basal Cell/surgery , Skin Neoplasms/surgery , Female , Humans , Male , Middle Aged , Neoplasm, Residual , Reoperation , Retrospective Studies
11.
J Mol Cell Cardiol ; 33(7): 1321-30, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11437538

ABSTRACT

Cell transplantation has been proposed as a future therapy for various myocardial diseases. It is unknown, however, whether the encouraging results obtained in animal models of ischemia and reperfusion, cryoinjury or cardiomyopathy can be reproduced in the setting of permanent coronary artery occlusion and extensive myocardial infarction (MI). Embryonic cardiac cells were isolated and cultured for 3 days to confirm viability, morphology and to label cells with BrdU or the reporter gene LacZ. Seven days after extensive MI, rats were randomized to cell (1.5x10(6)) transplantation (n=11) or culture medium injection (n=16) into the myocardial scar. Echocardiography study was performed before and 53+/-3 days after implantation to assess left ventricular (LV) remodeling and function. During follow-up, there was no mortality among cell-treated rats v 4 of 16 control rats (P=0.12). X-gal staining, BrdU and alpha -SMA immunohistochemistry identified the engrafted cells 1 week, 4 weeks and 8 weeks after transplantation, respectively. Antibodies against alpha -SMA, connexin-43, fast and slow myosin heavy chain revealed grafts in various stages of differentiation in 10 of 11 cell-treated hearts. Many of them, however, kept their embryonic phenotype and were isolated from the host myocardium by scar tissue. Serial echocardiography studies revealed that cell transplantation prevented scar thinning, LV dilatation and dysfunction while control animals developed scar thinning, significant LV dilatation accompanied by progressive deterioration in LV contractility. Transplantation of embryonic cardiomyocytes after extensive MI in a rat model attenuate LV dilatation, infarct thinning, and myocardial dysfunction. Still, many grafts remain isolated and do not differentiate into an adult phenotype, even when studied 2 months after grafting.


Subject(s)
Cell Transplantation/physiology , Fetal Heart/pathology , Myocardial Infarction/therapy , Animals , Cell Differentiation , Cell Survival , Cell Transplantation/methods , Disease Models, Animal , Disease Progression , Echocardiography/instrumentation , Female , Myocardial Infarction/complications , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/pathology , Neovascularization, Pathologic , Rats , Rats, Sprague-Dawley , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/etiology
12.
Dermatology ; 202(1): 52-3, 2001.
Article in English | MEDLINE | ID: mdl-11244231

ABSTRACT

Cherry angiomas are the most common vascular proliferation; however, little is known about the pathogenesis and etiology of these lesions. We present two laboratory technicians who were exposed to brominated compounds for prolonged periods and who developed multiple cherry angiomas on the trunk and extremities. We suggest that the association between exposure to bromides and cherry angiomas should be investigated by a controlled study.


Subject(s)
Bromides/adverse effects , Hemangioma/chemically induced , Skin Neoplasms/chemically induced , Adult , Female , Hemangioma/pathology , Humans , Middle Aged , Occupational Exposure/adverse effects , Skin/drug effects , Skin/pathology , Skin Neoplasms/pathology
13.
J Dermatolog Treat ; 12(3): 171-3, 2001 Sep.
Article in English | MEDLINE | ID: mdl-12243710

ABSTRACT

BACKGROUND: Multiple miliary osteoma cutis of the face represents primary extra-skeletal bone formation that arises within the skin of the face. METHODS: A 60-year-old woman with multiple miliary osteoma cutis of the face was treated by application of 0.05% tretinoin (all-trans-retinoic acid) cream nightly. RESULTS: After 3 months of therapy there were fewer papules and a decrease in size of remaining lesions. In a literature search, it was found that local application of tretinoin was successful and achieved a decrease in the number of papules over the face in all patients with multiple miliary osteoma cutis of the face; however, the length of time to achieve response varied from a few weeks to 6 months. CONCLUSION: It is suggested that local application of tretinoin cream should be considered in the therapy of multiple miliary osteoma cutis of the face, particularly when the lesions are small and superficial.


Subject(s)
Facial Dermatoses/drug therapy , Keratolytic Agents/administration & dosage , Ossification, Heterotopic/drug therapy , Skin Diseases/drug therapy , Tretinoin/administration & dosage , Administration, Topical , Facial Dermatoses/pathology , Female , Humans , Middle Aged , Ossification, Heterotopic/pathology , Skin Diseases/pathology
14.
Mt Sinai J Med ; 67(4): 333-5, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11021786

ABSTRACT

A left subfrontopolar lesion with marked edema was totally resected utilizing a minimally invasive approach. It was possible to expose and resect the lesion, which turned out to be a tuberculoma, through a burr hole placed supraorbitally through a glabellar incision. The development and significance of minimalization techniques for surgery in the skull base region are discussed.


Subject(s)
Larynx/surgery , Orbit/surgery , Skull Base , Trephining/methods , Tuberculoma/surgery , Tuberculosis, Osteoarticular/surgery , Female , Humans , Middle Aged , Tomography, X-Ray Computed , Tuberculoma/diagnostic imaging , Tuberculoma/pathology , Tuberculosis, Osteoarticular/diagnostic imaging , Tuberculosis, Osteoarticular/pathology
15.
Australas J Dermatol ; 41(1): 48-9, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10715902

ABSTRACT

A 60-year-old woman presented with a 3-week history of a pruritic papulo-nodular eruption on the face and trunk after a bee sting. Histological examination showed a predominantly lymphocytic infiltrate with follicular centres and tingible body macrophages. Immunohistochemically, positive staining for both kappa and lambda light chains was noted. The eruption settled with oral antihistamine and topical corticosteroid. These findings support the diagnosis of follicular B-cell pseudolymphoma.


Subject(s)
Bees , Facial Dermatoses/etiology , Insect Bites and Stings/complications , Pseudolymphoma/etiology , Animals , Facial Dermatoses/diagnosis , Facial Dermatoses/drug therapy , Facial Dermatoses/pathology , Female , Histamine H1 Antagonists/therapeutic use , Humans , Middle Aged , Pseudolymphoma/diagnosis , Pseudolymphoma/drug therapy , Pseudolymphoma/pathology
18.
Cancer Res ; 59(5): 1029-35, 1999 Mar 01.
Article in English | MEDLINE | ID: mdl-10070959

ABSTRACT

Expression of cytokines in malignant cells represents a novel approach for therapeutic treatment of tumors. Previously, we demonstrated the immunostimulatory effectiveness of interleukin 1alpha (IL-1alpha) gene transfer in experimental fibrosarcoma tumors. Here, we report the antitumor and immunotherapeutic effects of short-term expression of IL-1alpha by malignant T lymphoma cells. Activation in culture of T lymphoma cells with lipopolysaccharide-stimulated macrophages induces the expression of IL-1alpha. The short-term expression of IL-1alpha persists in the malignant T cells for a few days (approximately 3-6 days) after termination of the in vitro activation procedure and, thus, has the potential to stimulate antitumor immune responses in vivo. As an experimental tumor model, we used the RO1 invasive T lymphoma cell line. Upon i.v. inoculation, these cells invade the vertebral column and compress the spinal cord, resulting in hind leg paralysis and death of the mice. Activated RO1 cells, induced to express IL-1alpha in a short-term manner, manifested reduced tumorigenicity: approximately 75% of the mice injected with activated RO1 cells remained tumor free. IL-1 was shown to be essential for the eradication of activated T lymphoma cells because injection of activated RO1 cells together with IL-1-specific inhibitors, i.e., the IL-1 receptor antagonist or the M 20 IL-1 inhibitor, reversed reduced tumorigenicity patterns and led to progressive tumor growth and death of the mice. Furthermore, activated RO1 cells could serve as a treatment by intervening in the growth of violent RO1 cells after tumor take. Thus, when activated RO1 cells were injected 6 or 9 days after the inoculation of violent cells, mortality was significantly reduced. IL-1alpha, in its unique membrane-associated form, in addition to its cytosolic and secreted forms, may represent a focused adjuvant for potentiating antitumor immune responses at low levels of expression, below those that are toxic to the host. Further assessment of the immunotherapeutic potential of short-term expression of IL-1alpha in activated tumor cells may allow its improved application in the treatment of malignancies.


Subject(s)
Gene Expression Regulation, Neoplastic , Genetic Therapy , Interleukin-1/genetics , Lymphokines/therapeutic use , Lymphoma, T-Cell/immunology , Lymphoma, T-Cell/therapy , Sialoglycoproteins/therapeutic use , Animals , Cell Division , Death , Female , Gene Transfer Techniques , Growth Inhibitors/therapeutic use , Immunotherapy , Interleukin 1 Receptor Antagonist Protein , Interleukin-1/antagonists & inhibitors , Interleukin-1/pharmacology , Lipopolysaccharides/pharmacology , Lymphocyte Activation , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/pathology , Macrophage Activation , Macrophages/immunology , Mice , Mice, Inbred BALB C , Neoplasm Invasiveness , Paralysis , Recombinant Proteins/pharmacology , Spinal Neoplasms/pathology , Spinal Neoplasms/secondary , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Tumor Cells, Cultured
19.
Anticancer Res ; 15(1): 211-8, 1995.
Article in English | MEDLINE | ID: mdl-7537485

ABSTRACT

In the present study we used monoclonal antibodies to investigate the expression of phosphotyrosine, c-myc and c-Ha-ras proteins along the crypt continuum of normal and transformed rat colon tissue. Colon cancer was induced by administration of dimethylhydrazine. Particular attention was focused on the immunohistochemical pattern of murine colon mucosa during preneoplastic stages so as to permit the identification of putative changes in the expression/location of the oncoproteins prior to frank neoplasia. The immunohistochemical analysis of tyrosinephosphorylated proteins in the normal rat indicated that positive staining was mostly restricted to the lower colonic crypt zones. The carcinogenetic insult altered the magnitude and positional profile of phosphotyrosine along the colon crypt axis during the preneoplastic period. An intense positive reaction was observed in the upper crypt regions. Four weeks following the last DHM administration, viz. before tumor appearance, positive staining was evident in invasive adenocarcinoma tissue. In contrast to phosphotyrosine, the feeble c-myc immunohistochemical staining of normal rat colonic did not exhibit a focal topology. However, following DMH administration and prior to frank neoplasia, a substantial increase in the staining intensity for c-myc was noted, confined mostly to the supranuclear region of luminal cells. Invasive adenocarcinomas displayed intense cytoplasmic c-myc immunoreactivity. p21 c-Ha-ras expression and location along the colon crypt axis showed a different pattern when compared to p62 c-myc and phosphotyrosine. The p21 c-Ha-ras protein was prominently expressed in surface epithelium of normal and DMH-treated rats. Midcrypt colonocytes exhibited moderate p21 ras staining; in contrast, proliferating colonic cells resident in the lower crypt regions were consistently negative. These results suggest that c-Ha-ras gene product plays an important contributory role in determining the differentiated phenotype of the colonic cell.


Subject(s)
Adenocarcinoma/metabolism , Carcinogens/toxicity , Colon/metabolism , Colonic Neoplasms/metabolism , Dimethylhydrazines/toxicity , Proto-Oncogene Proteins c-myc/biosynthesis , Tyrosine/analogs & derivatives , 1,2-Dimethylhydrazine , Adenocarcinoma/chemically induced , Adenocarcinoma/pathology , Animals , Antibodies, Monoclonal , Cell Transformation, Neoplastic , Colon/cytology , Colonic Neoplasms/chemically induced , Colonic Neoplasms/pathology , Epithelial Cells , Epithelium/drug effects , Epithelium/metabolism , Genes, myc , Genes, ras , Immunohistochemistry , Male , Phosphotyrosine , Proto-Oncogene Proteins c-myc/analysis , Proto-Oncogene Proteins p21(ras)/analysis , Proto-Oncogene Proteins p21(ras)/biosynthesis , Rats , Tyrosine/analysis , Tyrosine/metabolism
20.
Anticancer Res ; 10(6): 1747-53, 1990.
Article in English | MEDLINE | ID: mdl-2285253

ABSTRACT

Tyrosine protein kinase (TPK) co-isolated with subcellular components derived from human colonic epithelium. The highest TPK activity, measured in the Triton X-100-insoluble cytoskeletal pellet, was directly related to the degree of malignancy of colonic tissue. TPK activity was assayed by measuring the incorporation of [gamma-32P] from [gamma-32]ATP into the synthetic polymer [Glu80Tyr20]n substrate. Lineweaver-Burk plots yielded an apparent Km of 167 micrograms/ml for [Glu80Tyr20]n and of 19 microM for ATP: Vmax for the phosphate donor was 0.9 nmol/min/mg protein. TPK activity was markedly stimulated by the metal ions Mg2+ and Mn2+ and significantly suppressed by tyrphostins, potent specific TPK inhibitors, shown to interfere with TPK-dependent growth processes. This is first report to present evidence for TPK activity associated with cytoskeleton-enriched subcellular preparations harvested from human colonic epithelium.


Subject(s)
Colon/enzymology , Colonic Neoplasms/enzymology , Intestinal Mucosa/enzymology , Protein-Tyrosine Kinases/metabolism , Benzylidene Compounds/pharmacology , Colonic Neoplasms/pathology , Colonic Neoplasms/ultrastructure , Cytoskeleton/enzymology , Cytoskeleton/ultrastructure , Epithelium/enzymology , Epithelium/pathology , Epithelium/ultrastructure , Humans , Intestinal Mucosa/pathology , Intestinal Mucosa/ultrastructure , Kinetics , Microscopy, Electron , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL